|
rdf:type |
|
|
lifeskim:mentions |
|
|
pubmed:issue |
5
|
|
pubmed:dateCreated |
2006-5-8
|
|
pubmed:abstractText |
This study was designed to review the clinical characteristics of surgically treated gastrointestinal stromal tumors of the colon and rectum, evaluate their immunohistochemical and pathologic features based on the current National Institutes of Health criteria, and correlate clinicopathologic findings with the subsequent clinical course.
|
|
pubmed:language |
eng
|
|
pubmed:journal |
|
|
pubmed:citationSubset |
IM
|
|
pubmed:chemical |
|
|
pubmed:status |
MEDLINE
|
|
pubmed:month |
May
|
|
pubmed:issn |
0012-3706
|
|
pubmed:author |
|
|
pubmed:issnType |
Print
|
|
pubmed:volume |
49
|
|
pubmed:owner |
NLM
|
|
pubmed:authorsComplete |
Y
|
|
pubmed:pagination |
609-15
|
|
pubmed:dateRevised |
2009-11-19
|
|
pubmed:meshHeading |
pubmed-meshheading:16552495-Adult,
pubmed-meshheading:16552495-Aged,
pubmed-meshheading:16552495-Aged, 80 and over,
pubmed-meshheading:16552495-Antigens, CD34,
pubmed-meshheading:16552495-Colonic Neoplasms,
pubmed-meshheading:16552495-Female,
pubmed-meshheading:16552495-Gastrointestinal Stromal Tumors,
pubmed-meshheading:16552495-Humans,
pubmed-meshheading:16552495-Immunohistochemistry,
pubmed-meshheading:16552495-Male,
pubmed-meshheading:16552495-Middle Aged,
pubmed-meshheading:16552495-Neoplasm Metastasis,
pubmed-meshheading:16552495-Neoplasm Staging,
pubmed-meshheading:16552495-Proto-Oncogene Proteins c-kit,
pubmed-meshheading:16552495-Receptor, Platelet-Derived Growth Factor alpha,
pubmed-meshheading:16552495-Rectal Neoplasms,
pubmed-meshheading:16552495-Risk Assessment
|
|
pubmed:year |
2006
|
|
pubmed:articleTitle |
Clinical, pathologic, and immunohistochemical characteristics of gastrointestinal stromal tumors of the colon and rectum: implications for surgical management and adjuvant therapies.
|
|
pubmed:affiliation |
Division of Colon and Rectal Surgery, Mayo Clinic, 200 First Street SW, Rochester, Minnesota 55905, USA.
|
|
pubmed:publicationType |
Journal Article
|
